A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-3305
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control ; volume:4 ; number:1 ; day:7 ; month:10 ; year:2011 ; pages:1-7 ; date:12.2011
Parasites & vectors ; 4, Heft 1 (7.10.2011), 1-7, 12.2011
- Creator
-
Zhou, Yi-biao
Zheng, Hui-min
Jiang, Qing-wu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-3305-4-194
- URN
-
urn:nbn:de:101:1-2021081920333708291995
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhou, Yi-biao
- Zheng, Hui-min
- Jiang, Qing-wu
- SpringerLink (Online service)
Other Objects (12)
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Estimating the prevalence of schistosomiasis japonica in China: a serological approach
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
A novel fluorescence immunochromatographic assay strip for the diagnosis of schistosomiasis japonica
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial
Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Inhibition of COX-2 ameliorates murine liver schistosomiasis japonica through splenic cellular immunoregulation
Biltricide/Praziquantel (Bayer)
Correction: Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Estimating the prevalence of schistosomiasis japonica in China: a serological approach
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
A novel fluorescence immunochromatographic assay strip for the diagnosis of schistosomiasis japonica
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial
Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Inhibition of COX-2 ameliorates murine liver schistosomiasis japonica through splenic cellular immunoregulation
Biltricide/Praziquantel (Bayer)
Correction: Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Estimating the prevalence of schistosomiasis japonica in China: a serological approach
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
A novel fluorescence immunochromatographic assay strip for the diagnosis of schistosomiasis japonica
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial
Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Inhibition of COX-2 ameliorates murine liver schistosomiasis japonica through splenic cellular immunoregulation
Biltricide/Praziquantel (Bayer)